Combination chemotherapy in isolation perfusion: use of mitotic inhibitors in pretreatment of V x 2 carcinoma undergoing isolation perfusion with alkylating agents.
D000470:Alkaloids / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D010478:Chemotherapy, Cancer, Regional Perfusion; D003078:Colchicine / Q000627:therapeutic use*; D003703:Demecolcine / Q000627:therapeutic use; D004347:Drug Interactions; D004357:Drug Synergism; D005260:Female; D006614:Hindlimb; D008558:Melphalan / Q000627:therapeutic use*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D011817:Rabbits; D013997:Time Factors; D014747:Vinblastine / Q000627:therapeutic use*
D000470:Alkaloids; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D014747:Vinblastine; D008558:Melphalan; D003078:Colchicine; D003703:Demecolcine